HEADER SIGNALING PROTEIN/TRANSCRIPTION 22-MAR-11 2LB0 TITLE STRUCTURE OF THE FIRST WW DOMAIN OF HUMAN SMURF1 IN COMPLEX WITH A DI- TITLE 2 PHOSPHORYLATED HUMAN SMAD1 DERIVED PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE SMURF1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 235-267; COMPND 5 SYNONYM: HSMURF1, SMAD UBIQUITINATION REGULATORY FACTOR 1, SMAD- COMPND 6 SPECIFIC E3 UBIQUITIN-PROTEIN LIGASE 1; COMPND 7 EC: 6.3.2.-; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 1; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: RESIDUES 208-217; COMPND 13 SYNONYM: MAD HOMOLOG 1, MOTHERS AGAINST DPP HOMOLOG 1, JV4-1, MAD- COMPND 14 RELATED PROTEIN 1, SMAD FAMILY MEMBER 1, SMAD 1, SMAD1, HSMAD1, COMPND 15 TRANSFORMING GROWTH FACTOR-BETA-SIGNALING PROTEIN 1, BSP-1; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SMURF1, KIAA1625; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PETM11; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606 KEYWDS SMURF, SMAD, CDK, SIGNAL TRANSDUCTION, SIGNALING PROTEIN- KEYWDS 2 TRANSCRIPTION COMPLEX EXPDTA SOLUTION NMR NUMMDL 21 AUTHOR M.J.MACIAS,E.ARAGON,N.GOERNER,A.ZAROMYTIDOU,Q.XI,A.ESCOBEDO, AUTHOR 2 J.MASSAGUE REVDAT 1 06-JUL-11 2LB0 0 JRNL AUTH E.ARAGON,N.GOERNER,A.I.ZAROMYTIDOU,Q.XI,A.ESCOBEDO, JRNL AUTH 2 J.MASSAGUE,M.J.MACIAS JRNL TITL A SMAD ACTION TURNOVER SWITCH OPERATED BY WW DOMAIN READERS JRNL TITL 2 OF A PHOSPHOSERINE CODE. JRNL REF GENES DEV. V. 25 1275 2011 JRNL REFN ISSN 0890-9369 JRNL PMID 21685363 JRNL DOI 10.1101/GAD.2060811 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-KUNSTLEVE, REMARK 3 JIANG,KUSZEWSKI,NILGES,PANNU,READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LB0 COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-APR-11. REMARK 100 THE RCSB ID CODE IS RCSB102176. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 285 REMARK 210 PH : 7 REMARK 210 IONIC STRENGTH : 0.420 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM NEDD4LWW3-1, 3 MM SMAD3-2, REMARK 210 20 MM SODIUM PHOSPHATE-3, 100 MM REMARK 210 SODIUM CHLORIDE-4, 2 MM SODIUM REMARK 210 AZIDE-5, 90% H2O/10% D2O; 1 MM [U REMARK 210 -100% 15N] NEDD4LWW3-6, 3 MM REMARK 210 SMAD3-7, 20 MM SODIUM PHOSPHATE- REMARK 210 8, 100 MM SODIUM CHLORIDE-9, 2 MM REMARK 210 SODIUM AZIDE-10, 90% H2O/10% D2O; REMARK 210 1 MM [U-100% 13C; U-100% 15N] REMARK 210 NEDD4LWW3-11, 3 MM SMAD3-12, 20 REMARK 210 MM SODIUM PHOSPHATE-13, 100 MM REMARK 210 SODIUM CHLORIDE-14, 2 MM SODIUM REMARK 210 AZIDE-15, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H NOESY; 2D 1H-1H TOCSY; REMARK 210 3D CBCA(CO)NH; 3D HNCACB; 2D 1H- REMARK 210 15N HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CNS 1.3, XEASY, TOPSPIN, NMRPIPE REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 300 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 21 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH ACCEPTABLE REMARK 210 COVALENT GEOMETRY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-21 REMARK 465 RES C SSSEQI REMARK 465 GLY A 232 REMARK 465 ALA A 233 REMARK 465 MET A 234 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HD13 LEU A 253 HG3 PRO B 212 1.26 REMARK 500 HB3 ASP A 264 HG12 ILE A 267 1.36 REMARK 500 HD22 LEU A 253 HA SER A 260 1.38 REMARK 500 H ASP B 211 HD3 PRO B 212 1.57 REMARK 500 OE1 GLU A 241 H3 THR B 208 1.58 REMARK 500 HH TYR A 251 O3P SEP B 210 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 10 THR A 257 26.09 -146.05 REMARK 500 10 PHE B 216 63.99 -115.11 REMARK 500 19 GLU A 238 96.44 -69.54 REMARK 500 19 THR A 257 24.84 -144.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 THR A 255 GLN A 256 2 147.56 REMARK 500 THR A 255 GLN A 256 3 149.34 REMARK 500 THR A 255 GLN A 256 4 146.96 REMARK 500 THR A 255 GLN A 256 5 150.00 REMARK 500 THR A 255 GLN A 256 7 142.43 REMARK 500 THR A 255 GLN A 256 8 147.49 REMARK 500 THR A 255 GLN A 256 9 148.24 REMARK 500 THR A 255 GLN A 256 11 147.89 REMARK 500 THR A 255 GLN A 256 12 148.47 REMARK 500 THR A 255 GLN A 256 13 149.22 REMARK 500 THR A 255 GLN A 256 14 146.26 REMARK 500 THR A 255 GLN A 256 15 147.78 REMARK 500 THR A 255 GLN A 256 16 146.00 REMARK 500 THR A 255 GLN A 256 17 147.60 REMARK 500 THR A 255 GLN A 256 19 145.66 REMARK 500 THR A 255 GLN A 256 21 147.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 17542 RELATED DB: BMRB REMARK 900 RELATED ID: 2LAW RELATED DB: PDB REMARK 900 RELATED ID: 2LAX RELATED DB: PDB REMARK 900 RELATED ID: 2LAY RELATED DB: PDB REMARK 900 RELATED ID: 2LAZ RELATED DB: PDB REMARK 900 RELATED ID: 2LB1 RELATED DB: PDB REMARK 900 RELATED ID: 2LB2 RELATED DB: PDB REMARK 900 RELATED ID: 2LB3 RELATED DB: PDB DBREF 2LB0 A 235 267 UNP Q9HCE7 SMUF1_HUMAN 235 267 DBREF 2LB0 B 208 217 UNP Q15797 SMAD1_HUMAN 208 217 SEQADV 2LB0 GLY A 232 UNP Q9HCE7 EXPRESSION TAG SEQADV 2LB0 ALA A 233 UNP Q9HCE7 EXPRESSION TAG SEQADV 2LB0 MET A 234 UNP Q9HCE7 EXPRESSION TAG SEQRES 1 A 36 GLY ALA MET GLU LEU PRO GLU GLY TYR GLU GLN ARG THR SEQRES 2 A 36 THR VAL GLN GLY GLN VAL TYR PHE LEU HIS THR GLN THR SEQRES 3 A 36 GLY VAL SER THR TRP HIS ASP PRO ARG ILE SEQRES 1 B 10 THR SER SEP ASP PRO GLY SEP PRO PHE GLN MODRES 2LB0 SEP B 210 SER PHOSPHOSERINE MODRES 2LB0 SEP B 214 SER PHOSPHOSERINE HET SEP B 210 14 HET SEP B 214 14 HETNAM SEP PHOSPHOSERINE HETSYN SEP PHOSPHONOSERINE FORMUL 2 SEP 2(C3 H8 N O6 P) SHEET 1 A 3 GLU A 241 THR A 244 0 SHEET 2 A 3 VAL A 250 HIS A 254 -1 O LEU A 253 N GLU A 241 SHEET 3 A 3 VAL A 259 THR A 261 -1 O VAL A 259 N HIS A 254 LINK C SER B 209 N SEP B 210 1555 1555 1.32 LINK C SEP B 210 N ASP B 211 1555 1555 1.33 LINK C GLY B 213 N SEP B 214 1555 1555 1.32 LINK C SEP B 214 N PRO B 215 1555 1555 1.34 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 162 0 2 0 3 0 0 6 0 0 0 4 END